[Apoptosis and mechanisms in hepatitis C].
Ohtake
Takaaki
T
Third Department of Internal Medicine, Asahikawa Medical College.
Torimoto
Yoshihiro
Y
Kohgo
Yutaka
Y
D017209:Apoptosis / Q000502:physiology*; D053222:Fas Ligand Protein; D016174:Hepacivirus / Q000276:immunology*; D019698:Hepatitis C, Chronic / Q000209:etiology*; D006801:Humans; D008562:Membrane Glycoproteins / Q000378:metabolism / Q000502:physiology; D016328:NF-kappa B / Q000378:metabolism / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism / Q000502:physiology; D014758:Viral Core Proteins / Q000502:physiology; D019014:fas Receptor / Q000378:metabolism / Q000502:physiology
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D016328:NF-kappa B; D014409:Tumor Necrosis Factor-alpha; D014758:Viral Core Proteins; D019014:fas Receptor; C069130:nucleocapsid protein, Hepatitis C virus